what is the new digital currency

How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.Argentine President Millay: Negotiations on a free trade agreement with the Trump administration will be launched next year. Argentine President Millay said in a national televised speech on December 10 local time that he plans to negotiate a free trade agreement with the newly appointed Trump administration of the United States next year, and promised to make Argentina more independent from MERCOSUR. After the historic trade agreement between MERCOSUR and the European Union last week, he criticized that MERCOSUR has become a "prison" for member States. "Our ultimate goal in MERCOSUR is to improve the autonomy of the members of this group to the rest of the world." Millay said, "In this spirit, our primary goal will be to start a free trade agreement with the United States next year." He also mentioned on the same day that Argentina plans to cancel capital controls next year.Business community: The melamine market with insufficient demand is mainly weak and volatile. According to the commodity market analysis system of business community, the price of melamine is weak and volatile recently. As of December 11th, the benchmark price of melamine in the business community was 6,412.5 yuan/ton, which was 0.12% lower than 6,420 yuan/ton at the beginning of this month. This week, the overall price of melamine showed a stable trend, although there were small fluctuations, but there was no sharp rise or fall. This week, the production capacity of the melamine industry remained relatively stable, and there was no large-scale increase or decrease in production, which helped to maintain the smooth operation of the market. Some melamine production enterprises may adjust their inventory to cope with the fluctuation of raw material prices, thus stabilizing the market price to some extent. This week, the demand for melamine in downstream industries such as plates and coatings remained stable, and there was no obvious increase or decrease, which supported the melamine market to some extent. In the future, enterprises need to pay close attention to market dynamics and policy changes and formulate reasonable business strategies to deal with potential market risks.

The CSI A500ETF paid dividends for the first time. On December 11th, ICBC Credit Suisse announced the dividend, becoming the first CSI A500ETF product to announce the dividend. The dividend plan is to allocate 0.066 yuan for every 10 fund shares, the base date of income distribution is November 29, and the net value of fund shares on the base date is 1.0078 yuan. In addition, ICBC Credit Suisse CSI A500ETF's dividend registration date is December 13th, and the cash dividend payment date is December 18th.According to the Islamic Republic of Iran News Agency (IRNA), a senior Russian parliamentarian called for Iran to join the Ji 'an organization.AKIRA AMARI, a former Japanese parliamentarian, said that relying on TSMC alone for high-end chips is the biggest risk.

Ma Ying-jeou will lead the students of "Dajiu Academy" to visit the mainland. Xiao Xucen, CEO of Ma Ying-jeou Foundation, said today (11th) that Ma Ying-jeou will lead the students of "Dajiu Academy" to visit the mainland from December 18th to 26th at the invitation of the mainland. (Looking at the Taiwan Strait)Qianyuan Medicine established a research and development company in Shanghai. According to the enterprise search APP, Qianyuan Medicine Research and Development (Shanghai) Co., Ltd. was recently established, with Mao Rengang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; Technical service, technical development, technical consultation, technical exchange, technology transfer and technology popularization. Enterprise investigation shows that the company is wholly owned by Qianyuan Medicine.The concept of humanoid robot is active again and again. Wuzhou New Year, Hanyu Group have daily limit, while the concept of humanoid robot is active again and again. Wuzhou New Year, Hanyu Group, Astar, Fenda Technology have daily limit, and Keli Sensing and Tianyue Mathematics have followed up.